Global Parenteral Nutrition

Parenteral Nutrition Comprehensive Study by Type (Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes, Vitamins and Minerals), Application (Premature Infants, Neonates and Children, Geriatrics, Chronic Disease Patients), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2026

Parenteral Nutrition Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 5.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Parenteral nutrition is a medication given by the intravenous vaccination of nutrition, which includes protein, carbohydrate, minerals and electrolytes, and other trace elements for patients. who cannot eat food through tube feeding in infants as well as adults, due to the high prevalence and substantial rise in chronic diseases is driving the global parenteral nutrition market. Nowadays, parenteral nutrition becomes a changing face in Oncology, an effective type of nutrition. Individuals and healthcare authorities are paying extensive focus on limiting the mortality rate due to early birth and are thereby focus on the use of parenteral nutritionAccording to AMA, the market for Parenteral Nutrition is expected to register a CAGR of 5.4% during the forecast period to 2026. This growth is primarily driven by High Prevalence of Malnutrition, Increase in the Geriatric Population, Increased Novel Parenteral Nutrition Combination In The U.S. And Europe, Rise in Constant Rate of Chronic Diseases, Rise in Cancer, AIDS, Diabetes and Rise in Number of Pre-Term Birth Rates.

Globally, a noticeable market trend is evident New Product Development and Commercialization (Supplemental PN, Premixed PN Formulations, Lipid Emulsions). The Health Care sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Baxter International (United States), Hospira (United States), B. Braun Melsungen (Germany), Grifols International (Spain), Fresenius Kabi (Germany), Otsuka Pharmaceuticals Factory (Japan), Actavis (United States), Sichuan Kelun Pharmaceutical (China), Claris Lifesciences Limited (India) and Pfizer, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
Baxter International and ASPEN Collaborated and Launched an Educational Video Series on Appropriate Use of Parenteral Nutrition
In Mar 2019, Baxter International Announced the Launch of Clinolipid (20% Lipid Injectable Emulsion), A Proprietary Olive Oil-Based Lipid Emulsion, Where Baxter Featured Portfolio of Parenteral Nutrition to Focus on Malnourished Patients, and additionally Parenteral Nutrition defined “Smartpn Video Series” A Modern Medicine, Which Serve as Therapeutic Modality for All Age Groups Especially Those in the Acute and Critical Care Settings within Four Part of Series

Market Drivers
  • High Prevalence of Malnutrition
  • Increase in the Geriatric Population
  • Increased Novel Parenteral Nutrition Combination In The U.S. And Europe
  • Rise in Constant Rate of Chronic Diseases
  • Rise in Cancer, AIDS, Diabetes
  • Rise in Number of Pre-Term Birth Rates

Market Trend
  • New Product Development and Commercialization (Supplemental PN, Premixed PN Formulations, Lipid Emulsions)

Restraints
  • Increasing Rate of Metabolic Complications and Liver Diseases after Taking Parenteral Nutrition

Opportunities
Rising Cases of Preterm Birth, Which Leads To Malnutrition, Is a Key Reason Fuelling the Consumption of Parenteral Nutrition in Asia Pacific and Increase in Prevalence of Chronic Kidney Disorders In Highly Populated Countries, Such As China and India
Challenges
Parenteral Nutrition Facing Challenge to Provide Total Energy Requirements and Essential Fatty Acids

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Parenteral Nutrition Study Sheds Light on
— The Parenteral Nutrition Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Parenteral Nutrition industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Parenteral Nutrition industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solutions
  • Trace Elements
  • Electrolytes
  • Vitamins and Minerals
By Application
  • Premature Infants, Neonates and Children
  • Geriatrics
  • Chronic Disease Patients
By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Malnutrition
      • 3.2.2. Increase in the Geriatric Population
      • 3.2.3. Increased Novel Parenteral Nutrition Combination In The U.S. And Europe
      • 3.2.4. Rise in Constant Rate of Chronic Diseases
      • 3.2.5. Rise in Cancer, AIDS, Diabetes
      • 3.2.6. Rise in Number of Pre-Term Birth Rates
    • 3.3. Market Challenges
      • 3.3.1. Parenteral Nutrition Facing Challenge to Provide Total Energy Requirements and Essential Fatty Acids
    • 3.4. Market Trends
      • 3.4.1. New Product Development and Commercialization (Supplemental PN, Premixed PN Formulations, Lipid Emulsions)
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Parenteral Nutrition, by Type, Application, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Parenteral Nutrition (Value)
      • 5.2.1. Global Parenteral Nutrition by: Type (Value)
        • 5.2.1.1. Carbohydrates
        • 5.2.1.2. Parenteral Lipid Emulsion
        • 5.2.1.3. Single Dose Amino Acid Solutions
        • 5.2.1.4. Trace Elements
        • 5.2.1.5. Electrolytes
        • 5.2.1.6. Vitamins and Minerals
      • 5.2.2. Global Parenteral Nutrition by: Application (Value)
        • 5.2.2.1. Premature Infants, Neonates and Children
        • 5.2.2.2. Geriatrics
        • 5.2.2.3. Chronic Disease Patients
      • 5.2.3. Global Parenteral Nutrition by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Parenteral Nutrition Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Parenteral Nutrition (Volume)
      • 5.3.1. Global Parenteral Nutrition by: Type (Volume)
        • 5.3.1.1. Carbohydrates
        • 5.3.1.2. Parenteral Lipid Emulsion
        • 5.3.1.3. Single Dose Amino Acid Solutions
        • 5.3.1.4. Trace Elements
        • 5.3.1.5. Electrolytes
        • 5.3.1.6. Vitamins and Minerals
      • 5.3.2. Global Parenteral Nutrition by: Application (Volume)
        • 5.3.2.1. Premature Infants, Neonates and Children
        • 5.3.2.2. Geriatrics
        • 5.3.2.3. Chronic Disease Patients
      • 5.3.3. Global Parenteral Nutrition by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Parenteral Nutrition Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Parenteral Nutrition (Price)
      • 5.4.1. Global Parenteral Nutrition by: Type (Price)
  • 6. Parenteral Nutrition: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Baxter International (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hospira (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Grifols International (Spain)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fresenius Kabi (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Otsuka Pharmaceuticals Factory (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Actavis (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sichuan Kelun Pharmaceutical (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Claris Lifesciences Limited (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pfizer, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Parenteral Nutrition Sale, by Type, Application, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Parenteral Nutrition (Value)
      • 7.2.1. Global Parenteral Nutrition by: Type (Value)
        • 7.2.1.1. Carbohydrates
        • 7.2.1.2. Parenteral Lipid Emulsion
        • 7.2.1.3. Single Dose Amino Acid Solutions
        • 7.2.1.4. Trace Elements
        • 7.2.1.5. Electrolytes
        • 7.2.1.6. Vitamins and Minerals
      • 7.2.2. Global Parenteral Nutrition by: Application (Value)
        • 7.2.2.1. Premature Infants, Neonates and Children
        • 7.2.2.2. Geriatrics
        • 7.2.2.3. Chronic Disease Patients
      • 7.2.3. Global Parenteral Nutrition by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Parenteral Nutrition Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Parenteral Nutrition (Volume)
      • 7.3.1. Global Parenteral Nutrition by: Type (Volume)
        • 7.3.1.1. Carbohydrates
        • 7.3.1.2. Parenteral Lipid Emulsion
        • 7.3.1.3. Single Dose Amino Acid Solutions
        • 7.3.1.4. Trace Elements
        • 7.3.1.5. Electrolytes
        • 7.3.1.6. Vitamins and Minerals
      • 7.3.2. Global Parenteral Nutrition by: Application (Volume)
        • 7.3.2.1. Premature Infants, Neonates and Children
        • 7.3.2.2. Geriatrics
        • 7.3.2.3. Chronic Disease Patients
      • 7.3.3. Global Parenteral Nutrition by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Parenteral Nutrition Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Parenteral Nutrition (Price)
      • 7.4.1. Global Parenteral Nutrition by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Parenteral Nutrition: by Type(USD Million)
  • Table 2. Parenteral Nutrition Carbohydrates , by Region USD Million (2015-2020)
  • Table 3. Parenteral Nutrition Parenteral Lipid Emulsion , by Region USD Million (2015-2020)
  • Table 4. Parenteral Nutrition Single Dose Amino Acid Solutions , by Region USD Million (2015-2020)
  • Table 5. Parenteral Nutrition Trace Elements , by Region USD Million (2015-2020)
  • Table 6. Parenteral Nutrition Electrolytes , by Region USD Million (2015-2020)
  • Table 7. Parenteral Nutrition Vitamins and Minerals , by Region USD Million (2015-2020)
  • Table 8. Parenteral Nutrition: by Application(USD Million)
  • Table 9. Parenteral Nutrition Premature Infants, Neonates and Children , by Region USD Million (2015-2020)
  • Table 10. Parenteral Nutrition Geriatrics , by Region USD Million (2015-2020)
  • Table 11. Parenteral Nutrition Chronic Disease Patients , by Region USD Million (2015-2020)
  • Table 12. Parenteral Nutrition: by Distribution Channel(USD Million)
  • Table 13. Parenteral Nutrition Online , by Region USD Million (2015-2020)
  • Table 14. Parenteral Nutrition Offline , by Region USD Million (2015-2020)
  • Table 15. South America Parenteral Nutrition, by Country USD Million (2015-2020)
  • Table 16. South America Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 17. South America Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 18. South America Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 19. Brazil Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 20. Brazil Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 21. Brazil Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 22. Argentina Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 23. Argentina Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 24. Argentina Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 25. Rest of South America Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 26. Rest of South America Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 27. Rest of South America Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 28. Asia Pacific Parenteral Nutrition, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 31. Asia Pacific Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 32. China Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 33. China Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 34. China Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 35. Japan Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 36. Japan Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 37. Japan Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 38. India Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 39. India Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 40. India Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 41. South Korea Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 42. South Korea Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 43. South Korea Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 44. Taiwan Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 45. Taiwan Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 46. Taiwan Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 47. Australia Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 48. Australia Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 49. Australia Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 53. Europe Parenteral Nutrition, by Country USD Million (2015-2020)
  • Table 54. Europe Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 55. Europe Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 56. Europe Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 57. Germany Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 58. Germany Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 59. Germany Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 60. France Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 61. France Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 62. France Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 63. Italy Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 64. Italy Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 65. Italy Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 66. United Kingdom Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 67. United Kingdom Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 68. United Kingdom Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 69. Netherlands Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 70. Netherlands Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 71. Netherlands Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 72. Rest of Europe Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 74. Rest of Europe Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 75. MEA Parenteral Nutrition, by Country USD Million (2015-2020)
  • Table 76. MEA Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 77. MEA Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 78. MEA Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 79. Middle East Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 80. Middle East Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 81. Middle East Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 82. Africa Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 83. Africa Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 84. Africa Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 85. North America Parenteral Nutrition, by Country USD Million (2015-2020)
  • Table 86. North America Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 87. North America Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 88. North America Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 89. United States Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 90. United States Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 91. United States Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 92. Canada Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 93. Canada Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 94. Canada Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 95. Mexico Parenteral Nutrition, by Type USD Million (2015-2020)
  • Table 96. Mexico Parenteral Nutrition, by Application USD Million (2015-2020)
  • Table 97. Mexico Parenteral Nutrition, by Distribution Channel USD Million (2015-2020)
  • Table 98. Parenteral Nutrition Sales: by Type(Million Units)
  • Table 99. Parenteral Nutrition Sales Carbohydrates , by Region Million Units (2015-2020)
  • Table 100. Parenteral Nutrition Sales Parenteral Lipid Emulsion , by Region Million Units (2015-2020)
  • Table 101. Parenteral Nutrition Sales Single Dose Amino Acid Solutions , by Region Million Units (2015-2020)
  • Table 102. Parenteral Nutrition Sales Trace Elements , by Region Million Units (2015-2020)
  • Table 103. Parenteral Nutrition Sales Electrolytes , by Region Million Units (2015-2020)
  • Table 104. Parenteral Nutrition Sales Vitamins and Minerals , by Region Million Units (2015-2020)
  • Table 105. Parenteral Nutrition Sales: by Application(Million Units)
  • Table 106. Parenteral Nutrition Sales Premature Infants, Neonates and Children , by Region Million Units (2015-2020)
  • Table 107. Parenteral Nutrition Sales Geriatrics , by Region Million Units (2015-2020)
  • Table 108. Parenteral Nutrition Sales Chronic Disease Patients , by Region Million Units (2015-2020)
  • Table 109. Parenteral Nutrition Sales: by Distribution Channel(Million Units)
  • Table 110. Parenteral Nutrition Sales Online , by Region Million Units (2015-2020)
  • Table 111. Parenteral Nutrition Sales Offline , by Region Million Units (2015-2020)
  • Table 112. South America Parenteral Nutrition Sales, by Country Million Units (2015-2020)
  • Table 113. South America Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 114. South America Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 115. South America Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 116. Brazil Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 117. Brazil Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 118. Brazil Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 119. Argentina Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 120. Argentina Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 121. Argentina Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 122. Rest of South America Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 123. Rest of South America Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 124. Rest of South America Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 125. Asia Pacific Parenteral Nutrition Sales, by Country Million Units (2015-2020)
  • Table 126. Asia Pacific Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 127. Asia Pacific Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 128. Asia Pacific Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 129. China Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 130. China Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 131. China Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 132. Japan Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 133. Japan Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 134. Japan Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 135. India Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 136. India Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 137. India Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 138. South Korea Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 139. South Korea Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 140. South Korea Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 141. Taiwan Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 142. Taiwan Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 143. Taiwan Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 144. Australia Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 145. Australia Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 146. Australia Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 147. Rest of Asia-Pacific Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 148. Rest of Asia-Pacific Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 149. Rest of Asia-Pacific Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 150. Europe Parenteral Nutrition Sales, by Country Million Units (2015-2020)
  • Table 151. Europe Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 152. Europe Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 153. Europe Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 154. Germany Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 155. Germany Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 156. Germany Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 157. France Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 158. France Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 159. France Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 160. Italy Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 161. Italy Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 162. Italy Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 163. United Kingdom Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 164. United Kingdom Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 165. United Kingdom Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 166. Netherlands Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 167. Netherlands Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 168. Netherlands Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 169. Rest of Europe Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 170. Rest of Europe Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 171. Rest of Europe Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 172. MEA Parenteral Nutrition Sales, by Country Million Units (2015-2020)
  • Table 173. MEA Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 174. MEA Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 175. MEA Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 176. Middle East Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 177. Middle East Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 178. Middle East Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 179. Africa Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 180. Africa Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 181. Africa Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 182. North America Parenteral Nutrition Sales, by Country Million Units (2015-2020)
  • Table 183. North America Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 184. North America Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 185. North America Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 186. United States Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 187. United States Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 188. United States Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 189. Canada Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 190. Canada Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 191. Canada Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 192. Mexico Parenteral Nutrition Sales, by Type Million Units (2015-2020)
  • Table 193. Mexico Parenteral Nutrition Sales, by Application Million Units (2015-2020)
  • Table 194. Mexico Parenteral Nutrition Sales, by Distribution Channel Million Units (2015-2020)
  • Table 195. Parenteral Nutrition: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Parenteral Nutrition: by Type(USD Million)
  • Table 207. Parenteral Nutrition Carbohydrates , by Region USD Million (2021-2026)
  • Table 208. Parenteral Nutrition Parenteral Lipid Emulsion , by Region USD Million (2021-2026)
  • Table 209. Parenteral Nutrition Single Dose Amino Acid Solutions , by Region USD Million (2021-2026)
  • Table 210. Parenteral Nutrition Trace Elements , by Region USD Million (2021-2026)
  • Table 211. Parenteral Nutrition Electrolytes , by Region USD Million (2021-2026)
  • Table 212. Parenteral Nutrition Vitamins and Minerals , by Region USD Million (2021-2026)
  • Table 213. Parenteral Nutrition: by Application(USD Million)
  • Table 214. Parenteral Nutrition Premature Infants, Neonates and Children , by Region USD Million (2021-2026)
  • Table 215. Parenteral Nutrition Geriatrics , by Region USD Million (2021-2026)
  • Table 216. Parenteral Nutrition Chronic Disease Patients , by Region USD Million (2021-2026)
  • Table 217. Parenteral Nutrition: by Distribution Channel(USD Million)
  • Table 218. Parenteral Nutrition Online , by Region USD Million (2021-2026)
  • Table 219. Parenteral Nutrition Offline , by Region USD Million (2021-2026)
  • Table 220. South America Parenteral Nutrition, by Country USD Million (2021-2026)
  • Table 221. South America Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 222. South America Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 223. South America Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 224. Brazil Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 225. Brazil Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 226. Brazil Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 227. Argentina Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 228. Argentina Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 229. Argentina Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 230. Rest of South America Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 231. Rest of South America Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 232. Rest of South America Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 233. Asia Pacific Parenteral Nutrition, by Country USD Million (2021-2026)
  • Table 234. Asia Pacific Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 235. Asia Pacific Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 236. Asia Pacific Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 237. China Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 238. China Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 239. China Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 240. Japan Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 241. Japan Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 242. Japan Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 243. India Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 244. India Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 245. India Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 246. South Korea Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 247. South Korea Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 248. South Korea Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 249. Taiwan Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 250. Taiwan Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 251. Taiwan Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 252. Australia Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 253. Australia Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 254. Australia Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 255. Rest of Asia-Pacific Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 256. Rest of Asia-Pacific Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 257. Rest of Asia-Pacific Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 258. Europe Parenteral Nutrition, by Country USD Million (2021-2026)
  • Table 259. Europe Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 260. Europe Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 261. Europe Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 262. Germany Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 263. Germany Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 264. Germany Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 265. France Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 266. France Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 267. France Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 268. Italy Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 269. Italy Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 270. Italy Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 271. United Kingdom Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 272. United Kingdom Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 273. United Kingdom Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 274. Netherlands Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 275. Netherlands Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 276. Netherlands Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 277. Rest of Europe Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 278. Rest of Europe Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 279. Rest of Europe Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 280. MEA Parenteral Nutrition, by Country USD Million (2021-2026)
  • Table 281. MEA Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 282. MEA Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 283. MEA Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 284. Middle East Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 285. Middle East Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 286. Middle East Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 287. Africa Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 288. Africa Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 289. Africa Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 290. North America Parenteral Nutrition, by Country USD Million (2021-2026)
  • Table 291. North America Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 292. North America Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 293. North America Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 294. United States Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 295. United States Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 296. United States Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 297. Canada Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 298. Canada Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 299. Canada Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 300. Mexico Parenteral Nutrition, by Type USD Million (2021-2026)
  • Table 301. Mexico Parenteral Nutrition, by Application USD Million (2021-2026)
  • Table 302. Mexico Parenteral Nutrition, by Distribution Channel USD Million (2021-2026)
  • Table 303. Parenteral Nutrition Sales: by Type(Million Units)
  • Table 304. Parenteral Nutrition Sales Carbohydrates , by Region Million Units (2021-2026)
  • Table 305. Parenteral Nutrition Sales Parenteral Lipid Emulsion , by Region Million Units (2021-2026)
  • Table 306. Parenteral Nutrition Sales Single Dose Amino Acid Solutions , by Region Million Units (2021-2026)
  • Table 307. Parenteral Nutrition Sales Trace Elements , by Region Million Units (2021-2026)
  • Table 308. Parenteral Nutrition Sales Electrolytes , by Region Million Units (2021-2026)
  • Table 309. Parenteral Nutrition Sales Vitamins and Minerals , by Region Million Units (2021-2026)
  • Table 310. Parenteral Nutrition Sales: by Application(Million Units)
  • Table 311. Parenteral Nutrition Sales Premature Infants, Neonates and Children , by Region Million Units (2021-2026)
  • Table 312. Parenteral Nutrition Sales Geriatrics , by Region Million Units (2021-2026)
  • Table 313. Parenteral Nutrition Sales Chronic Disease Patients , by Region Million Units (2021-2026)
  • Table 314. Parenteral Nutrition Sales: by Distribution Channel(Million Units)
  • Table 315. Parenteral Nutrition Sales Online , by Region Million Units (2021-2026)
  • Table 316. Parenteral Nutrition Sales Offline , by Region Million Units (2021-2026)
  • Table 317. South America Parenteral Nutrition Sales, by Country Million Units (2021-2026)
  • Table 318. South America Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 319. South America Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 320. South America Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 321. Brazil Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 322. Brazil Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 323. Brazil Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 324. Argentina Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 325. Argentina Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 326. Argentina Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 327. Rest of South America Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 328. Rest of South America Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 329. Rest of South America Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 330. Asia Pacific Parenteral Nutrition Sales, by Country Million Units (2021-2026)
  • Table 331. Asia Pacific Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 332. Asia Pacific Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 333. Asia Pacific Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 334. China Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 335. China Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 336. China Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 337. Japan Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 338. Japan Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 339. Japan Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 340. India Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 341. India Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 342. India Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 343. South Korea Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 344. South Korea Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 345. South Korea Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 346. Taiwan Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 347. Taiwan Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 348. Taiwan Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 349. Australia Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 350. Australia Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 351. Australia Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 352. Rest of Asia-Pacific Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 353. Rest of Asia-Pacific Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 354. Rest of Asia-Pacific Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 355. Europe Parenteral Nutrition Sales, by Country Million Units (2021-2026)
  • Table 356. Europe Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 357. Europe Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 358. Europe Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 359. Germany Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 360. Germany Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 361. Germany Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 362. France Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 363. France Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 364. France Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 365. Italy Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 366. Italy Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 367. Italy Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 368. United Kingdom Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 369. United Kingdom Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 370. United Kingdom Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 371. Netherlands Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 372. Netherlands Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 373. Netherlands Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 374. Rest of Europe Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 375. Rest of Europe Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 376. Rest of Europe Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 377. MEA Parenteral Nutrition Sales, by Country Million Units (2021-2026)
  • Table 378. MEA Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 379. MEA Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 380. MEA Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 381. Middle East Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 382. Middle East Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 383. Middle East Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 384. Africa Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 385. Africa Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 386. Africa Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 387. North America Parenteral Nutrition Sales, by Country Million Units (2021-2026)
  • Table 388. North America Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 389. North America Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 390. North America Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 391. United States Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 392. United States Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 393. United States Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 394. Canada Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 395. Canada Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 396. Canada Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 397. Mexico Parenteral Nutrition Sales, by Type Million Units (2021-2026)
  • Table 398. Mexico Parenteral Nutrition Sales, by Application Million Units (2021-2026)
  • Table 399. Mexico Parenteral Nutrition Sales, by Distribution Channel Million Units (2021-2026)
  • Table 400. Parenteral Nutrition: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Parenteral Nutrition: by Type USD Million (2015-2020)
  • Figure 5. Global Parenteral Nutrition: by Application USD Million (2015-2020)
  • Figure 6. Global Parenteral Nutrition: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Parenteral Nutrition Share (%), by Country
  • Figure 8. Asia Pacific Parenteral Nutrition Share (%), by Country
  • Figure 9. Europe Parenteral Nutrition Share (%), by Country
  • Figure 10. MEA Parenteral Nutrition Share (%), by Country
  • Figure 11. North America Parenteral Nutrition Share (%), by Country
  • Figure 12. Global Parenteral Nutrition: by Type Million Units (2015-2020)
  • Figure 13. Global Parenteral Nutrition: by Application Million Units (2015-2020)
  • Figure 14. Global Parenteral Nutrition: by Distribution Channel Million Units (2015-2020)
  • Figure 15. South America Parenteral Nutrition Share (%), by Country
  • Figure 16. Asia Pacific Parenteral Nutrition Share (%), by Country
  • Figure 17. Europe Parenteral Nutrition Share (%), by Country
  • Figure 18. MEA Parenteral Nutrition Share (%), by Country
  • Figure 19. North America Parenteral Nutrition Share (%), by Country
  • Figure 20. Global Parenteral Nutrition: by Type USD/Units (2015-2020)
  • Figure 21. Global Parenteral Nutrition share by Players 2020 (%)
  • Figure 22. Global Parenteral Nutrition share by Players (Top 3) 2020(%)
  • Figure 23. Global Parenteral Nutrition share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 26. Baxter International (United States) Revenue: by Geography 2020
  • Figure 27. Hospira (United States) Revenue, Net Income and Gross profit
  • Figure 28. Hospira (United States) Revenue: by Geography 2020
  • Figure 29. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 30. B. Braun Melsungen (Germany) Revenue: by Geography 2020
  • Figure 31. Grifols International (Spain) Revenue, Net Income and Gross profit
  • Figure 32. Grifols International (Spain) Revenue: by Geography 2020
  • Figure 33. Fresenius Kabi (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Fresenius Kabi (Germany) Revenue: by Geography 2020
  • Figure 35. Otsuka Pharmaceuticals Factory (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Otsuka Pharmaceuticals Factory (Japan) Revenue: by Geography 2020
  • Figure 37. Actavis (United States) Revenue, Net Income and Gross profit
  • Figure 38. Actavis (United States) Revenue: by Geography 2020
  • Figure 39. Sichuan Kelun Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 40. Sichuan Kelun Pharmaceutical (China) Revenue: by Geography 2020
  • Figure 41. Claris Lifesciences Limited (India) Revenue, Net Income and Gross profit
  • Figure 42. Claris Lifesciences Limited (India) Revenue: by Geography 2020
  • Figure 43. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Pfizer, Inc. (United States) Revenue: by Geography 2020
  • Figure 45. Global Parenteral Nutrition: by Type USD Million (2021-2026)
  • Figure 46. Global Parenteral Nutrition: by Application USD Million (2021-2026)
  • Figure 47. Global Parenteral Nutrition: by Distribution Channel USD Million (2021-2026)
  • Figure 48. South America Parenteral Nutrition Share (%), by Country
  • Figure 49. Asia Pacific Parenteral Nutrition Share (%), by Country
  • Figure 50. Europe Parenteral Nutrition Share (%), by Country
  • Figure 51. MEA Parenteral Nutrition Share (%), by Country
  • Figure 52. North America Parenteral Nutrition Share (%), by Country
  • Figure 53. Global Parenteral Nutrition: by Type Million Units (2021-2026)
  • Figure 54. Global Parenteral Nutrition: by Application Million Units (2021-2026)
  • Figure 55. Global Parenteral Nutrition: by Distribution Channel Million Units (2021-2026)
  • Figure 56. South America Parenteral Nutrition Share (%), by Country
  • Figure 57. Asia Pacific Parenteral Nutrition Share (%), by Country
  • Figure 58. Europe Parenteral Nutrition Share (%), by Country
  • Figure 59. MEA Parenteral Nutrition Share (%), by Country
  • Figure 60. North America Parenteral Nutrition Share (%), by Country
  • Figure 61. Global Parenteral Nutrition: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Baxter International (United States)
  • Hospira (United States)
  • B. Braun Melsungen (Germany)
  • Grifols International (Spain)
  • Fresenius Kabi (Germany)
  • Otsuka Pharmaceuticals Factory (Japan)
  • Actavis (United States)
  • Sichuan Kelun Pharmaceutical (China)
  • Claris Lifesciences Limited (India)
  • Pfizer, Inc. (United States)
Select User Access Type

Key Highlights of Report


Aug 2021 212 Pages 51 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Parenteral Nutrition Quantitative research analysis
Global Parenteral Nutrition Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Parenteral Nutrition market is expected to see a CAGR of 5.4% during projected year 2020 to 2026.
Top performing companies in the Global Parenteral Nutrition market are Baxter International (United States), Hospira (United States), B. Braun Melsungen (Germany), Grifols International (Spain), Fresenius Kabi (Germany), Otsuka Pharmaceuticals Factory (Japan), Actavis (United States), Sichuan Kelun Pharmaceutical (China), Claris Lifesciences Limited (India) and Pfizer, Inc. (United States), to name a few.
North America is dominating the Parenteral Nutrition Market.

Know More About Global Parenteral Nutrition Report?

Have a Query? Click Here

Other Related Reports

Pediatric Nutrition Comprehensive Study by Type (Milk-based, Soy-based, Organic, Others), Application (Brain Development, Nutrition Source, Metabolic Disorders, Allergy Management), Formulation Type ...
$ 3450
RNAi for Therapeutic Comprehensive Study by Type (Small interfering RNAs (siRNA), Short hairpin RNAs (shRNA)), Application (Neurodegenerative Disease, Cardiovascular Disease, Viral Infection, RNAi-Ba...
$ 4500
Infection Control Comprehensive Study by Type (Hand Disinfectants, Skin Disinfectants, Instrument Disinfectants, Surface Disinfectants), Application (Hospitals & Clinics, Life Sciences Industry, Medi...
$ 3750
Monoclonal Antibody Based Products Comprehensive Study by Type (Murine, Chimeric, Humanized, Human), Application (Therapeutics, Diagnostics), Diseases Type (Non-communicable Diseases, Infectious Dise...
$ 3800
Disposable Cuvettes Comprehensive Study by Type (Polystyrene, Methacrylate), Capacity (Below 10 ml, 10-20 ml, Above 20 ml), End Use (Chemical, Healthcare & Medical, Food Sector, Environmental Protect...
$ 3450
Neuromodulation Devices Comprehensive Study by Type (Internal Neuromodulation, External Neuromodulation), Application (Depression, Parkinsons Disease, Tremor, Others), End Users (Hospitals, Clinics, ...
$ 3450